tiprankstipranks
Advertisement
Advertisement

Pro Medicus reshapes senior leadership to support global imaging growth

Story Highlights
  • Pro Medicus has restructured leadership, moving CFO Clayton Hatch into new operations and investor relations roles.
  • Danny English is promoted to CFO, reinforcing succession planning as Pro Medicus pursues global imaging growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Pro Medicus reshapes senior leadership to support global imaging growth

Claim 55% Off TipRanks

Pro Medicus Limited ( (AU:PME) ) has issued an announcement.

Pro Medicus has reshaped its senior leadership, appointing long-serving Chief Financial Officer Clayton Hatch to the newly created dual roles of Head of Business Operations and Head of Investor Relations, where he will oversee operational initiatives to drive growth, productivity and profitability while managing engagement with the investment community. The company has promoted Danny English, previously Head of Finance and Company Secretary, to Chief Financial Officer, a move the CEO says highlights deliberate succession planning and internal talent depth as Pro Medicus pursues its ambition to remain a leading provider of enterprise medical imaging solutions.

The management changes are designed to align financial stewardship, operational execution and investor communication more closely with the company’s global growth strategy and expanding footprint in advanced imaging technologies. By elevating experienced insiders with extensive governance and international finance credentials, Pro Medicus signals continuity in leadership and a reinforced focus on risk management, performance and long-term value creation for stakeholders.

The most recent analyst rating on (AU:PME) stock is a Hold with a A$145.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.

More about Pro Medicus Limited

Pro Medicus Limited is an ASX-listed healthcare informatics company that provides a comprehensive suite of medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide. Through its Visage 7 platform and related RIS, PACS, AI and e-health solutions, the company delivers scalable, cloud-ready enterprise imaging systems from offices in Melbourne, Berlin and San Diego.

YTD Price Performance: -39.62%

Average Trading Volume: 427,848

Technical Sentiment Signal: Hold

Current Market Cap: A$13.89B

Find detailed analytics on PME stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1